fbpx

REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search
Covid-19

Sheba Tests New Kit that Smells the COVID-19 Pathogen

New Kit that Smells the COVID-19
NanoScent’s new testing kit implements a sensor-based smelling system to detect the virus in its earliest stages. Results are available in 30 seconds, with a 90% success rate.

Israeli startup NanoScent has developed a new test that uses nanoscale sensors to “smell” the pathogen that identifies COVID-19 carriers. The Israeli Innovation Authority and the Health Ministry helped to fund the design and development of this innovative testing kit.

The kit is composed of a disposable piece that connects to the nose, which is manufactured by Netafim, an Israeli company, along with electronic components manufactured by DreamTech, a South Korean company. Together, these elements work to sniff out a coronavirus patient within 30 seconds, and the results show a success rate of 90%.

How does the NanoScent kit work? Vapors are emitted by the decomposition process that occurs when the COVID-19 contagion enters the host’s nose or pharynx, and the device absorbs these vapors. This means that the kit can also identify asymptomatic coronavirus carriers – as soon as four days after the initial infection.

To test the pilot product, Sheba Medical Center has used it among dozens of patients. It has also been tested at several Magen David Adom drive-in test stations, as well as at Ichilov Hospital in Tel Aviv, and at Poriya Hospital in Tiberias.

The NanoScent test is not intended to replace the current swab-based diagnosis of the virus, but rather to provide an initial indication of infection. It is designed to serve a function that’s similar – yet more accurate – to the current temperature checks performed before entry to crowded places. For example, the testing kit can be utilized at airports, offices, stadiums, schools and campuses, and cultural institutions.

Thus far, several major international companies have already expressed interest in purchasing the product from NanoScent.

Related
Sheba Leverages ChatGPT
Accelerating Diagnostics: ChatGPT Results Aligned with Breast Cancer Board Recommendations
Recently, several distinguished Sheba clinicians were impressed by the tool’s capabilities. The group, which included Dr. Vera Sorin, Dr. Eyal Klang, Dr. Miri Sklair-Levy, Prof.…
Read More
Sheba and Vidac
Novel Drug Set to Improve CAR T-Cell Therapy Effectiveness
While many medical centers around the world depend on external labs to genetically engineer patient T-cells, a process that can take up to a few…
Read More
Sheba Named Global Oncology Leader
by Newsweek Magazine
Dedicated to providing those in need across the globe ‘Hope Without Boundaries,’ Sheba treats patients from more than 100 countries each year, employing the latest…
Read More